Marshall Wace
AMRI

Marshall Wace’s Albany Molecular Research Inc AMRI Stock Holding History

Marshall Wace’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-30,540
Closed -$606K – 1299
2015
Q4 		$606K Buy
+30,540
New +$580K 0.01% 778
2014
Q4 		– Sell
-86,543
Closed -$1.91M – 1080
2014
Q3 		$1.91M Buy
86,543
+46,310
+115% +$948K 0.03% 450
2014
Q2 		$809K Buy
+40,233
New +$681K 0.01% 537

Other funds holding AMRI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Marshall Wace's AMRI Position: Q1 2016 in Review

Marshall Wace sold out of Albany Molecular Research Inc (AMRI) in Q1 2016, closing a stake of 30,540 shares — an estimated $606K sold.

Marshall Wace first reported a position in AMRI in Q2 2014 and held it in 3 quarters. The position peaked at $1.91M in Q3 2014. 141 funds tracked by Wall St. Rank hold AMRI as of Q1 2016.

  • Marshall Wace reported no remaining Albany Molecular Research Inc position as of Q1 2016 after selling out during the quarter.
  • Marshall Wace sold 30,540 Albany Molecular Research Inc shares in Q1 2016, an estimated $606K.
  • Marshall Wace first reported a position in Albany Molecular Research Inc in Q2 2014 and held it in 3 quarters.
  • Marshall Wace's Albany Molecular Research Inc position peaked at $1.91M in Q3 2014.
  • 141 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2016.

Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.